Concepedia
Statistics
Publications
13
Citations
475
H-Index
11
Active since
2013
Affiliations
Candiolo Cancer Institute(Current)
University of Turin
Istituti di Ricovero e Cura a Carattere Scientifico
Fondazione Edo ed Elvo Tempia
Massachusetts General Hospital
Marco Basiricò is an author at Candiolo Cancer Institute specializing in oncology, molecular oncology, and medicine.
Publications per year
2013–2023
The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models
Ymera Pignochino, Carmine Dell’Aglio, Marco Basiricò et al. · Clinical Cancer Research · 2013 · 108 citations
Medicine, Oncology, Pharmacology +17
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models
Ymera Pignochino, Federica Capozzi, Lorenzo D’Ambrosio et al. · Molecular Cancer · 2017 · 71 citations · Full text
Medicine, Oncology, Pharmacology +16
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody
Martina Sanlorenzo, Igor Vujic, Arianna Floris et al. · Clinical Cancer Research · 2018 · 53 citations · Full text
Pharmacy, Immunology, Oncology +17
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Valeria Leuci, Chiara Donini, Giovanni Grignani et al. · Clinical Cancer Research · 2020 · 44 citations · Full text
Life Sciences, Immunology, Oncology +15
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma
Ymera Pignochino, Carmine Dell’Aglio, Simona Inghilleri et al. · BMC Cancer · 2015 · 34 citations · Full text
1–5 of 13